Oracle Unveils Oracle® Health Sciences Cloud

OracleOracle announced that its portfolio of Oracle Health Sciences Cloud Applications will be powered by the next-generation Oracle® Health Sciences Cloud, a scalable and secure software-as-a-service delivery platform tailored for the specific requirements and regulations of the health sciences market.

The enhanced Oracle Health Sciences Cloud delivers life sciences and healthcare applications with unparalleled performance, scalability and security. It supports the increasingly networked environment for research, clinical development, and healthcare delivery wherein data must be effectively and securely managed across multiple organizations, including life sciences companies, contract research organizations (CROs), academic medical centers, and regulators and outsourcing vendors.

In conjunction with Oracle Health Sciences Cloud Applications, Oracle Health Sciences Cloud will help health sciences organizations further accelerate IT deployments, reduce resources required to maintain IT infrastructure and gain a more predictable IT spending pattern. Oracle Health Sciences Cloud is developed and rigorously tested for the specific security and privacy requirements of the health sciences industry. This HIPAA certified cloud provides full qualification and validation testing for each instance of the deployed application and is compliant with U.S. Food & Drug Administration (FDA) 21 CFR Part 11.

Oracle Health Sciences solutions currently available as a service on the Oracle Health Sciences Cloud include electronic data capture, electronic patient reported outcomes, study design, coding and dictionary management, trial randomization and drug supply management, research clinic automation, as well as safety management and will expand over time. The Oracle Health Sciences Cloud currently hosts over 3,800 application instances supporting hundreds of thousands of users and millions of transactions per day in more than 117 countries.

The new Oracle Health Sciences Cloud will take advantage of Oracle’s hardware and software, including Oracle Fusion Middleware, Oracle Exadata Database Machine, and Oracle’s Sun ZFS Storage Appliance.

"Delivering cloud applications that support the stringent regulatory environment and networked nature of clinical trials requires not only technical expertise, but significant industry expertise, as well," said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences. "Oracle Health Sciences Cloud and our proven portfolio of Oracle Health Sciences Cloud Applications offer customers a formidable combination of scalability, data security, value, and confidence."

Related news articles:

About Oracle
Oracle is the world's most complete, open, and integrated business software and hardware systems company. For more information about Oracle, please visit http://www.oracle.com.

Most Popular Now

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...